Innovative Diagnostic Technologies and Their Significance for Personalized Medicine Kewal K. Jain Current Opinion 16 August 2012 Pages: 141 - 147
Identification of Cancer Autoantigens in Serum J. Ignacio CasalRodrigo Barderas Leading Article 16 August 2012 Pages: 149 - 154
Programmed Cell Death 4 (PDCD4) Enhances the Sensitivity of Gastric Cancer Cells to TRAIL-Induced Apoptosis by Inhibiting the PI3K/Akt Signaling Pathway Wei-Qiang WangHao ZhangDian-Chun Fang Original Research Article 16 August 2012 Pages: 155 - 161
Prognostic Value of IDH1 Mutations Identified with PCR-RFLP Assay in Glioblastoma Patients Mateusz BujkoPaulina KoberJanusz A. Siedlecki Original Research Article 16 August 2012 Pages: 163 - 169
Response to Methadone Maintenance Treatment is Associated with the MYOCD and GRM6 Genes Francina FonsecaMònica GratacòsMarta Torrens Original Research Article 16 August 2012 Pages: 171 - 178
Clinical Characteristics and PTPN22 1858C/T Variant Analysis in Jordanian Arab Vitiligo Patients Asem AlkhateebFiras QarqazTasnim Al Rashaideh Original Research Article 16 August 2012 Pages: 179 - 184
Melting Point Assay for the JAK2 V617F Mutation, Comparison with Amplification Refractory Mutation System (ARMS) in Diagnostic Samples, and Implications for Daily Routine Sebastian OchsenreitherMark ReinwaldThomas Burmeister Technology Report 16 August 2012 Pages: 185 - 190
C-Reactive Protein as a Clinically Useful Biomarker of Metastasis of Renal Cell Carcinoma Timothy V. JohnsonAndrew N. YoungViraj A. Master Case Report 16 August 2012 Pages: 191 - 193